ES557306A0 - Procedimiento para preparar derivados de acido quinoloncarboxilico - Google Patents

Procedimiento para preparar derivados de acido quinoloncarboxilico

Info

Publication number
ES557306A0
ES557306A0 ES557306A ES557306A ES557306A0 ES 557306 A0 ES557306 A0 ES 557306A0 ES 557306 A ES557306 A ES 557306A ES 557306 A ES557306 A ES 557306A ES 557306 A0 ES557306 A0 ES 557306A0
Authority
ES
Spain
Prior art keywords
acid derivatives
chinoloncarboxylic
preparing
procedure
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557306A
Other languages
English (en)
Other versions
ES8802148A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of ES8802148A1 publication Critical patent/ES8802148A1/es
Publication of ES557306A0 publication Critical patent/ES557306A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Table Devices Or Equipment (AREA)
  • Steroid Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES557306A 1984-11-13 1987-01-13 Procedimiento para preparar derivados de acido quinoloncarboxilico Expired ES8802148A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59239124 1984-11-13

Publications (2)

Publication Number Publication Date
ES8802148A1 ES8802148A1 (es) 1988-04-01
ES557306A0 true ES557306A0 (es) 1988-04-01

Family

ID=17040142

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548800A Expired ES8704929A1 (es) 1984-11-13 1985-11-12 Procedimiento para preparar derivados de acido quinoloncar- boxilico
ES557306A Expired ES8802148A1 (es) 1984-11-13 1987-01-13 Procedimiento para preparar derivados de acido quinoloncarboxilico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES548800A Expired ES8704929A1 (es) 1984-11-13 1985-11-12 Procedimiento para preparar derivados de acido quinoloncar- boxilico

Country Status (21)

Country Link
EP (1) EP0183129B1 (es)
JP (1) JPH0637490B2 (es)
KR (2) KR930004652B1 (es)
CN (1) CN1011587B (es)
AT (1) ATE45354T1 (es)
AU (1) AU591640B2 (es)
CA (2) CA1290338C (es)
DE (1) DE3572170D1 (es)
DK (1) DK173185B1 (es)
ES (2) ES8704929A1 (es)
FI (1) FI83219C (es)
GR (1) GR852758B (es)
HU (1) HU198471B (es)
IE (1) IE58356B1 (es)
IN (2) IN162769B (es)
MX (1) MX162894B (es)
NO (1) NO163568C (es)
NZ (1) NZ214156A (es)
PH (1) PH21007A (es)
PT (1) PT81476B (es)
ZA (1) ZA858699B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
JPS62108878A (ja) * 1985-11-05 1987-05-20 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体およびその製造方法
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS63179856A (ja) * 1987-01-21 1988-07-23 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法並びにその中間体
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US4885386A (en) * 1988-10-28 1989-12-05 Warner-Lambert Company Process for the synthesis of 3-chloro-2,4,5-trifluorobenzoic acid
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
ES2018977A6 (es) * 1989-11-29 1991-05-16 Marga Investigacion Procedimiento de preparacion de n-ciclopropil-4-fluoroanilinas.
FR2673426B1 (fr) * 1991-03-01 1993-07-16 Bouchara Sa Nouvelles quinolones, leur procede de preparation et les compositions en refermant.
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
CN1065802C (zh) * 1992-02-08 2001-05-16 大野家建 研磨机及其自动化装置
EP0688772B1 (en) * 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
JPH0637490B2 (ja) 1994-05-18
IE852790L (en) 1986-05-13
FI83219B (fi) 1991-02-28
CA1282412C (en) 1991-04-02
FI854445A (fi) 1986-05-14
IN164295B (es) 1989-02-11
KR930004652B1 (ko) 1993-06-02
MX162894B (es) 1991-07-08
CA1290338C (en) 1991-10-08
ES548800A0 (es) 1987-04-16
NO163568B (no) 1990-03-12
IE58356B1 (en) 1993-09-08
ATE45354T1 (de) 1989-08-15
GR852758B (es) 1986-02-25
ES8802148A1 (es) 1988-04-01
AU4946185A (en) 1986-05-22
KR860004025A (ko) 1986-06-16
FI854445A0 (fi) 1985-11-12
DE3572170D1 (de) 1989-09-14
HU198471B (en) 1989-10-30
PT81476B (pt) 1987-11-11
DK519985D0 (da) 1985-11-12
EP0183129A1 (en) 1986-06-04
NO854522L (no) 1986-05-14
EP0183129B1 (en) 1989-08-09
NO163568C (no) 1990-06-20
HUT40101A (en) 1986-11-28
DK173185B1 (da) 2000-03-06
CN1011587B (zh) 1991-02-13
FI83219C (fi) 1991-06-10
PT81476A (en) 1985-12-01
JPS61267573A (ja) 1986-11-27
ZA858699B (en) 1986-07-30
AU591640B2 (en) 1989-12-14
PH21007A (en) 1987-06-23
KR920006236B1 (ko) 1992-08-01
IN162769B (es) 1988-07-09
DK519985A (da) 1986-07-01
CN85109026A (zh) 1986-07-30
KR860004049A (ko) 1986-06-16
ES8704929A1 (es) 1987-04-16
NZ214156A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
ES557306A0 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
ES509242A0 (es) "procedimiento para preparar nuevos compuestos de cefem".
PT82854B (pt) Processo para a preparacao de derivados do acido piridono-carboxilico
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
IT1205958B (it) Derivati di acido chinolincarbossilico e procedimento per la loro preparazione
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES8606283A1 (es) Procedimiento para preparar derivados de acidos quinolon- carboxilicos
ES548196A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
GR3006108T3 (es)

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170627